Cortes, J., Kantarjian, H. M., Rea, D., Wetzler, M., Lipton, J. H., Akard, L., . . . Nicolini, F. E. (2015). Final Analysis of Efficacy and Safety of Omacetaxine Mepesuccinate in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML): 24-Month Minimum Follow-Up Results. Cancer.
Styl ChicagoCortes, Jorge, et al. "Final Analysis of Efficacy and Safety of Omacetaxine Mepesuccinate in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML): 24-Month Minimum Follow-Up Results." Cancer 2015.
Citace podle MLACortes, Jorge, et al. "Final Analysis of Efficacy and Safety of Omacetaxine Mepesuccinate in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML): 24-Month Minimum Follow-Up Results." Cancer 2015.